ctrl K

Watchlist Price Alert

Syros Pharmaceuticals Inc... (SYRS)

NASDAQ: SYRS · Real-Time Price · USD

0.03

0.00 (19.52%)

At close: Jun 09, 2025, 3:26 PM

Syros Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	9.94M	14.88M	23.49M	15.09M	1.98M	2.05M	1.1M	317K
Cost of Revenue	2.25M	2.97M	n/a	n/a	n/a	n/a	1.53M	n/a
Gross Profit	7.68M	11.91M	23.49M	15.09M	1.98M	2.05M	-426K	317K
Operating Income	-128.99M	-135.87M	-99.42M	-82.3M	-77.74M	-64.3M	-54.69M	-47.96M
Interest Income	6.82M	2.13M	87K	426K	2.3M	n/a	n/a	n/a
Pretax Income	-164.57M	-94.65M	-86.56M	-84.04M	-75.44M	-62.28M	-54.01M	-47.74M
Net Income	-164.57M	-49.3M	-90.47M	-85.83M	-75.44M	-62.28M	-54.01M	-47.74M
Selling & General & Admin	28.28M	29.3M	23.04M	21.32M	21.48M	16.16M	13.89M	10.46M
Research & Development	108.15M	111.94M	99.87M	76.06M	58.24M	50.18M	41.9M	37.82M
Other Expenses	n/a	-9.51M	n/a	n/a	2.3M	2.02M	676K	220K
Operating Expenses	138.92M	141.24M	122.91M	97.39M	79.72M	66.35M	55.79M	48.28M
Interest Expense	5.13M	4.13M	3.91M	1.79M	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	138.92M	141.24M	122.91M	97.39M	79.72M	66.35M	55.79M	48.28M
Income Tax Expense	n/a	-45.35M	3.91M	1.79M	2.55M	2.02M	-1.53M	n/a
Shares Outstanding (Basic)	28.33M	12.63M	6.25M	4.61M	4.02M	3.27M	2.54M	1.27M
Shares Outstanding (Diluted)	28.33M	12.63M	6.25M	4.61M	4.02M	3.27M	2.54M	1.27M
EPS (Basic)	-5.81	-3.9	-14.47	-18.64	-18.76	-19.07	-21.26	-37.6
EPS (Diluted)	-5.81	-3.9	-14.47	-18.64	-18.76	-19.07	-21.26	-37.6
EBITDA	-157.19M	-87.55M	-79.63M	-79.21M	-72.72M	-60.67M	-53.16M	-46.69M
EBIT	-159.45M	-90.52M	-82.65M	-82.25M	-75.44M	-62.28M	-54.69M	-47.96M
Depreciation & Amortization	2.25M	2.97M	3.02M	3.04M	2.72M	1.6M	1.53M	1.27M